Amer Zeidan to Co-Moderate High-Risk MDS Session at 2026 Scientific Symposium
Amer Zeidan and Hetty Carraway

Amer Zeidan to Co-Moderate High-Risk MDS Session at 2026 Scientific Symposium

Amer Zeidan, Professor of Medicine, Chief of Hematologic Malignancies, Director of Heme Clinical Research at Yale University, shared a post on LinkedIn:

“Join us for the 2026 Scientific Symposium: the only international meeting focusing on bone marrow failure. Please to co-moderate the higher risk MDSsm with Dr Hetty Carraway where outstanding faculty discuss the latest developments in field. Hope many of you can join us for what promises to be a superb meeting.”

Amer Zeidan

Other articles featuring MDS on OncoDaily.